רקובל 12 以色列 - 希伯来文 - Ministry of Health

רקובל 12

ferring pharmaceuticals ltd - follitropin delta - תמיסה להזרקה - follitropin delta 12 mcg / 0.36 ml - follitropin delta

רקובל 36 以色列 - 希伯来文 - Ministry of Health

רקובל 36

ferring pharmaceuticals ltd - follitropin delta - תמיסה להזרקה - follitropin delta 36 mcg / 1.08 ml - follitropin delta

רקובל 72 以色列 - 希伯来文 - Ministry of Health

רקובל 72

ferring pharmaceuticals ltd - follitropin delta - תמיסה להזרקה - follitropin delta 72 mcg / 2.16 ml - follitropin delta

אקטיק 200 מקג 以色列 - 希伯来文 - Ministry of Health

אקטיק 200 מקג

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 200 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

אקטיק 600 מקג 以色列 - 希伯来文 - Ministry of Health

אקטיק 600 מקג

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 600 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

אקטיק 1200 מקג 以色列 - 希伯来文 - Ministry of Health

אקטיק 1200 מקג

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 1200 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

סקופולמין הידרוברומיד 0.25 מ"ג/ מ"ל 以色列 - 希伯来文 - Ministry of Health

סקופולמין הידרוברומיד 0.25 מ"ג/ מ"ל

teva pharmaceutical indust.ltd - scopolamine hydrobromide 0.25 mg/ml - solution for injection - scopolamine - scopolamine is used in cases where antimuscarinic action is desired, such as in premedication, where reduction of excitement and production of amnesia, in conjunction with morphine or pethidine, are desired.

איקסל 25 מג 以色列 - 希伯来文 - Ministry of Health

איקסל 25 מג

perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

מבטרה 10 מגמל תוך ורידי 以色列 - 希伯来文 - Ministry of Health

מבטרה 10 מגמל תוך ורידי

roche pharmaceuticals (israel) ltd - rituximab - תרכיז להכנת תמיסה לאינפוזיה - rituximab 10 mg/ml - rituximab - rituximab - mabthera is indicated for the following indications: * non-hodgkin’s lymphoma (nhl)mabthera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, b-cell non-hodgkin’s lymphoma.mabthera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy mabthera is indicated for the treatment of patients with cd20 positive diffuse large b-cell non-hodgkin's lymphoma in combination with chop chemotherapy. mabthera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * chronic lymphocytic leukaemia (cll)mabthera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including mabthera or patients refractory to previous mabthera plu

גזייבה 以色列 - 希伯来文 - Ministry of Health

גזייבה

roche pharmaceuticals (israel) ltd - obinutuzumab - תרכיז להכנת תמיסה לאינפוזיה - obinutuzumab 1000 mg / 40 ml - obinutuzumab